Why Wegovy Costs So Much (and 5 Ways to Pay Less)

Wegovy at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2021
• Route: subcutaneous injection (single-dose pen)
• Typical frequency: once weekly
• Half-life: approximately 7 days
• Cash price (US): $1,300-$1,400/month without insurance
• Receptor target: GLP-1 receptor

Cost is the most common reason people stop Wegovy, even when it's working. Knowing the full landscape — insurance, savings programs, cash pay, alternatives — usually opens up an option people didn't know they had.

Wegovy Cash Price

Without insurance, Wegovy runs $1,300-$1,400/month without insurance in the US market.

That number is the starting point — what you actually pay depends on:

• Insurance status (commercial, Medicare, Medicaid, uninsured)
• Manufacturer savings programs (where applicable)
• Discount cards (GoodRx, Cost Plus Drug, manufacturer cards)
• Telehealth bundling (some platforms include the drug in a flat monthly fee)
• Pharmacy choice (chain vs independent vs mail-order)

Insurance Coverage

Coverage for weight loss varies widely; many commercial plans exclude obesity medications. Medicare currently does not cover Wegovy for weight loss alone.

The pattern across the GLP-1 / metabolic medication space is: coverage for diabetes is widespread, coverage for weight loss is improving but still inconsistent, and coverage for any off-label use is rare.

Manufacturer Programs

Novo Nordisk runs savings programs for eligible patients. Eligibility usually requires commercial insurance and an active prescription. Patients on Medicare or Medicaid generally aren't eligible.

Cash-Pay and Direct-from-Manufacturer Options

Several manufacturers have introduced direct-to-consumer cash channels for their GLP-1 products in response to coverage gaps. These can lower the cash price meaningfully — see our guide to getting GLP-1 medications for current options.

Total Cost Over a Year

A monthly price of $1,300-$1,400/month without insurance translates to roughly $10,800-$18,000 per year out of pocket without insurance. That's a real number to plan around — many programs that look attractive at $200/month for the first three months reset to full price after the introductory window.

For weight management, the relevant question is whether to plan around long-term use; for GLP-1 medications, weight regain after stopping is well-documented.

Comparing to Alternatives

Common alternatives include Zepbound (tirzepatide, larger weight loss in head-to-head), Saxenda (liraglutide, daily injection), and compounded semaglutide (off-label). Some of those alternatives may be cheaper, covered when Wegovy isn't, or just better-suited for a particular case. See our cost comparison pages: linked above.

Bottom Line

The list price for Wegovy is real but rarely the final number. Build the cost plan into the treatment plan from day one, and revisit it whenever insurance or savings programs change.

Frequently Asked Questions

Related Reading

• What Is Wegovy? Everything You Should Know Before Starting
• Wegovy Side Effects: 7 Things to Watch For (and How to Manage Them)
• Wegovy Results: Realistic Expectations vs. Trial Headlines
• The Wegovy Dose Question Everyone Asks (Finally Answered)
• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile

Sources

• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.
• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.
• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.

Pricing changes frequently. The numbers on this page reflect publicly available information as of 2026-04-29 and should be verified at the point of purchase.